Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Crispr Therapeutics AG (CRSPN)

Mexico
Symbol
Exchange
Currency
CRSPNASDAQUSD
CRSPNBIVAMXN
CRSPNMexicoMXN
Currency in MXN
Disclaimer
960.00
0.00(0.00%)
Closed

CRSPN Comments

Editing your genes to live a longer? Or all the gold in the world?
Gap filled.
Absurd
Take note that another sickle cell stock, a compeititor to CRISPR, was ALSO approved today. It ALSO plummeted today in value, by 40%!The reasons for these drops are vastly different in the end and are why CRISPR is showing to be the likely winner in this field for 2 reasons:- Bluebird earned a black box warning for certain kinds of blood cancer today with its approval. I am a second year pharmacy student. In case you don’t know what a black box warning is, it’s the most dangerous, important, in your face side effect that practitioners MUST see before they prescribe treatments. This BBW is particularly nasty it seems, truly.- It has been announed that CRISPR will be almost 1 million dollars cheaper than bluebird’s treatment. That is huge. Bluebird will cost 3.1 million for treatment and CRISPR will cost 2.2 million for treatment. Bluebird costs more and has a horrib black box warning. CRISPR is cheaper and had NO black box warning given to it today. CRISPR is the obvious choice.
That other company is bluebird, in case I did not make it clear at the start of my comment.
Thanks for good info and thoughts Mark
Took profits. Buy back in at $50
Dont panic the same thing happened with the UK approval. The rally took a little bit to start
How long?
Anyone able to determine why the drop?
Options tomfoolery. The zero day derivatives market has gotten cartoonishly large.
They slashed 10% of their staff. Never good. But FDA approval is huge. Just have faith in the play. Takes a while for the big boys to get in.
It should skyrocket 30% up and it goes down wtf
Brutal, lol
Gotta love approving a Nobel award winning, first of its kind DNa editing treatment for nearly 100,000 people means an instant 8% drop, lol. Guess we just gotta hold and wait.
some knews about lapprovation?
The thing you and everyone else has been waiting for since this IPOd has happened. Why aren't you buying?
Buy…
hi guys 👋 please y'all should advice me if I should purchase CRSP stock and start investing
70K revenue when 1.8mil was expected? That can't be right?
Its $70M as per nasdaq.com !!
ARK tracking: On April 12th, the largest stock purchased by ARK was Crispr Therapeutics Ag, with a purchase amount of 2.5413 million US dollars, totaling 56500 shares, closing down 4.00%;
Any reason for tanking !! Although across the board every thing is in green
FDA is supposed to authorize marketing of first 2 end uses (sickle cell and hemophilia) until March .... ????
Time to load up
Nice price
The earning date posted here is wrong. Its 2/16/22. So miss leading
wow... it's bucking the trend
another cathy wood investment ¡ Good luck ...enjoy the elevator
CRISPR Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to CTX110™ for the Treatment of Relapsed or Refractory CD19+ B-cell malignanciesZUG, Switzerland and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) http://ir.crisprtx.com/news-releases/news-release-details/crispr-therapeutics-announces-fda-regenerative-medicine-advanced
Amazing how fast this went from breakthrough life changing technology to garbage in about a month
One paragraph of good news and this goes back to 160 in a day after the sheep pile in. Not just this ticker but any of them.
...
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.